Epileptogenic	epileptogenic	O	O	O	O
properties	properties	O	O	O	O
of	of	O	O	O	O
enflurane	enflurane	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
their	their	O	O	O	O
clinical	clinical	O	O	O	O
interpretation	interpretation	O	O	O	O
.	.	O	O	O	O

Three	three	O	O	O	O
cases	cases	O	O	O	O
of	of	O	O	O	O
EEG	eeg	O	O	O	O
changes	changes	O	O	O	O
induced	induced	O	O	O	O
by	by	O	O	O	O
single	single	O	O	O	O
exposure	exposure	O	O	O	O
to	to	O	O	O	O
enflurane	enflurane	CHEMICALS	O	OTHERS	I
anesthesia	anesthesia	O	O	O	O
are	are	O	O	O	O
reported	reported	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
one	one	O	O	O	O
patient	patient	O	O	O	O
,	,	O	O	O	O
enflurane	enflurane	CHEMICALS	O	OTHERS	I
administered	administered	O	O	O	O
during	during	O	O	O	O
a	a	O	O	O	O
donor	donor	O	O	O	O
nephrectomy	nephrectomy	O	O	O	O
resulted	resulted	O	O	O	O
in	in	O	O	O	O
unexpected	unexpected	O	O	O	O
partial	partial	O	O	O	O
motor	motor	O	O	O	O
seizures	seizures	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Until	until	O	O	O	O
the	the	O	O	O	O
cause	cause	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
seizures	seizures	O	DISEASE	OTHERS	I
was	was	O	O	O	O
correctly	correctly	O	O	O	O
identified	identified	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
patient	patient	O	O	O	O
was	was	O	O	O	O
inappropriately	inappropriately	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
anticonvulsants	anticonvulsants	O	O	O	O
.	.	O	O	O	O

Two	two	O	O	O	O
other	other	O	O	O	O
patients	patients	O	O	O	O
suffered	suffered	O	O	O	O
from	from	O	O	O	O
partial	partial	O	O	O	O
,	,	O	O	O	O
complex	complex	O	O	O	O
and	and	O	O	O	O
generalized	generalized	O	O	OTHERS	I
seizures	seizures	O	DISEASE	OTHERS	I
uncontrolled	uncontrolled	O	O	O	O
by	by	O	O	O	O
medication	medication	O	O	O	O
.	.	O	O	O	O

Epileptic	epileptic	O	DISEASE	OTHERS	I
foci	foci	O	O	O	O
delineated	delineated	O	O	O	O
and	and	O	O	O	O
activated	activated	O	O	O	O
by	by	O	O	O	O
enflurane	enflurane	CHEMICALS	O	OTHERS	I
were	were	O	O	O	O
surgically	surgically	O	O	O	O
ablated	ablated	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
patients	patients	O	O	O	O
are	are	O	O	O	O
now	now	O	O	O	O
seizure-free	seizure-free	O	O	O	O
.	.	O	O	O	O

Previous	previous	O	O	O	O
exposures	exposures	O	O	O	O
to	to	O	O	O	O
enflurane	enflurane	CHEMICALS	O	OTHERS	I
have	have	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
disclosed	disclosed	O	O	O	O
to	to	O	O	O	O
avoid	avoid	O	O	O	O
mistakes	mistakes	O	O	O	O
in	in	O	O	O	O
clinical	clinical	O	O	O	O
interpretation	interpretation	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
EEG	eeg	O	O	O	O
.	.	O	O	O	O

On	on	O	O	O	O
the	the	O	O	O	O
other	other	O	O	O	O
hand	hand	O	O	O	O
,	,	O	O	O	O
enflurane	enflurane	CHEMICALS	O	OTHERS	I
may	may	O	O	O	O
prove	prove	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
a	a	O	O	O	O
safe	safe	O	O	O	O
fast	fast	O	O	O	O
acting	acting	O	O	O	O
activator	activator	O	O	O	O
of	of	O	O	O	O
epileptic	epileptic	O	DISEASE	OTHERS	I
foci	foci	O	O	O	O
during	during	O	O	O	O
corticography	corticography	O	O	O	O
or	or	O	O	O	O
depth	depth	O	O	O	O
electrode	electrode	O	O	O	O
intraoperative	intraoperative	O	O	O	O
recordings	recordings	O	O	O	O
.	.	O	O	O	O

